Nature Medicine | Spoonful of Medicine
Results from two patients signals possible efficacy of stem cell-based eye therapy
Geron may have been the first company to launch a US trial with regulatory clearance involving a human embryonic stem cell (ESC)-derived product. But Advanced Cell Technology (ACT) made history itself today, becoming the first biotech to report results about such a product in a major peer-reviewed journal.
Recent comments
Real-time tissue analysis could guide brain tumor surgery
Bundled RNA balls silence brain cancer gene expression
Ebola outbreak in West Africa lends urgency to recently-funded research